微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 3.98% | -70.39% | 56.08% | 22/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 2.55% | -73.04% | 59.38% | 23/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 1.6% | -59.49% | -87.35% | 16/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 12.65% | -45.1% | -5.88% | 9/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 13.44% | -29.37% | 42.07% | 9/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 9.46% | -22.65% | 139.49% | 7/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 3.95% | 1.8% | -82.86% | 11/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 23.04% | 63.87% | 21.07% | 6/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 19.03% | 73.32% | 55.6% | 11/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 12.23% | 114.19% | 215.21% | 9/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 3.88% | 81.31% | -72.4% | 14/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 14.06% | -13.21% | 28.05% | 18/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 10.98% | -28.75% | 92.29% | 18/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 5.71% | -33.99% | 166.82% | 25/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 2.14% | -38.51% | -86.79% | 20/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 16.2% | -7.8% | 5.13% | 21/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 15.41% | 13.31% | 78.15% | 11/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 8.65% | 12.78% | 148.56% | 9/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | 3.48% | -3.33% | -80.19% | 4/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 17.57% | 8.06% | 29.19% | 16/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 13.6% | 12.3% | 77.31% | 10/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 7.67% | 14.82% | 113.06% | 8/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 3.6% | 18.42% | -77.86% | 7/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | 16.26% | 4.3% | 34.27% | 14/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 12.11% | 11.1% | 81.29% | 8/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 6.68% | 32.8% | 119.74% | 10/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 3.04% | 10.14% | -80.5% | 7/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 15.59% | -33.63% | 43.03% | 11/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 10.9% | -43.11% | 116.7% | 11/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 5.03% | -46.55% | 82.25% | 12/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 2.76% | 2% | -88.25% | 7/51 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | 23.49% | 29.21% | 22.6% | 6/51 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | 19.16% | 2% | 103.61% | 2/51 | 5.93% | 南华生物 | 383.03% | 行业排名> |
| 2016-06-30 | 9.41% | 2% | -48.24% | 7/51 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2015-12-31 | 18.18% | 34.37% | 34.37% | 9/51 | 22.23% | 药石科技 | 24.53% | 行业排名> |